To provide for the mandatory recall of drugs regulated by the Food and Drug Administration.
Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.
Summary
What This Bill Does
This bill, To provide for the mandatory recall of drugs regulated by the Food and Drug Administration., changes federal law or congressional policy affecting health care providers and patients. The main policy domain is Healthcare, Agriculture, Transportation.
Who Benefits and How
health care providers and patients may benefit from new authority, funding, eligibility, regulatory clarity, or reduced risk created by the bill.
Who Bears the Burden and How
federal implementing agencies, health care providers and patients may take on implementation duties, reporting obligations, compliance costs, or oversight responsibilities.
Key Provisions
- Section H183DCEE0BF8E49D4961FB7ED9225692E: 1. Short title This Act may be cited as the Recall Unsafe Drugs Act of 2023.
- Section H1DC18F83D39741C7891A1FCEAE980202: 2. Notification, nondistribution, and recall of adulterated or misbranded drugs Section 301 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 331) is...
- Section HD761856D3B894E8E991AB5A3DF263CBD: 569E. Notification, nondistribution, and recall of certain adulterated or misbranded drugs Any person required to register under section 510 shall, as soon as...
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.
At a Glance
What This Bill Does
This bill, To provide for the mandatory recall of drugs regulated by the Food and Drug Administration., changes federal law or congressional policy affecting health care providers and patients.
Key Policy Areas
Healthcare, Agriculture, Transportation
Primary Purpose
This bill, To provide for the mandatory recall of drugs regulated by the Food and Drug Administration., changes federal law or congressional policy affecting health care providers and patients.
Policy Domains
Whole bill
Identified Gains
- health care providers and patients
Identified Costs
- federal implementing agencies
- health care providers and patients
Legislative Progress
IntroducedMs. DeLauro introduced the following bill; which was referred to …
Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
- "the_secretary"
- → The Secretary identified in the operative section
- "the_commission"
- → The commission identified in the operative section
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology